Back to Search
Start Over
Boston Scientific's EPOCH trial of TheraSphere Y-90 Glass Microspheres to treat metastatic colorectal cancer meets primary and secondary endpoints
- Source :
- PharmaBiz. September 22, 2021
- Publication Year :
- 2021
-
Abstract
- Boston Scientific Corporation announced the EPOCH clinical trial of the TheraSphere Y-90 Glass Microspheres (TheraSphere treatment) successfully met both primary endpoints, including progression-free survival (PFS) and hepatic progression-free survival (hPFS) [...]
- Subjects :
- Boston Scientific Corp. -- Product development
Care and treatment
Product development
Medical equipment industry -- Product development
Chemotherapy
Medical research
Radiotherapy
Colorectal cancer -- Care and treatment
Liver
Cancer metastasis -- Care and treatment
Medicine, Experimental
Medical test kit industry -- Product development
Metastasis -- Care and treatment
Medical equipment and supplies industry -- Product development
Cancer -- Chemotherapy
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.676390258